TITLE:
A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.

CONDITION:
Diabetes Mellitus, Non-Insulin-Dependent

INTERVENTION:
Glucovance (metformin HCl/glyburide)

SUMMARY:

      The purpose of this clinical research study is to see if Glucovance, a medication currently
      approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and
      effectively in children 9 to 16 years of age.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 9 Years to 16 Years
Criteria:

        Children ages 9-16 years with a diagnosis of type 2 diabetes mellitus who are not
        adequately controlled with diet and exercise, with or without oral hypoglycemic therapy,
        and have an HbA1c greater than 6.4%
      
